Clinical value of TV-CDS combined with serum tumor markers in diagnosis of ovarian cancer

被引:12
|
作者
Yu, Chunying [1 ]
Dou, Ting [1 ]
Liu, Yun [1 ]
Liu, Ruirong [1 ]
机构
[1] Third Peoples Hosp Qingdao, Dept Ultrason Med, 29 Yongping Rd, Qingdao 266041, Shandong, Peoples R China
关键词
ovarian cancer; color doppler ultrasound; transvaginal; tumor markers; serology; combined examination; DOPPLER SONOGRAPHY; OSTEOPONTIN; STAGE; DISCRIMINATION; ULTRASOUND; CA125;
D O I
10.3892/ol.2020.11705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical application value was investigated of transvaginal color Doppler ultrasound (TV-CDS) combined with serum tumor markers carbohydrate antigen 125 (CA125), vascular endothelial growth factor (VEGF) and osteopontin (OPN) in the diagnosis of ovarian cancer (OC). One hundred and six patients with OC [malignant tumor group (MTG)] and fifty patients with benign ovarian diseases [benign control group (BCG)] were selected. Both groups of patients underwent TV-CDS examination. The lesion morphology and internal structure were observed, and the tumor blood flow signal, resistance index (RI) and pulsability index (PI) under ultrasound were determined. Serum CA125 was detected by electrochemiluminescence, and VEGF and OPN levels were detected by enzyme-linked immunosorbent assay. The incidence of irregular lesion morphology, unclear boundary, uneven internal echo, microcalcification and side-acoustic images in OC group (OCG) was significantly higher than that in BCG (P<0.01). As for blood flow grading, most patients in the MTG were in grade II and III, while most patients in the BCG were in grade 0. Compared with BCG, the flow RI and PI in the OCG were significantly reduced (P<0.01). The levels of serum CA125, VEGF and OPN in OCG were significantly higher than those in BCG. The expression levels of serum CA125, VEGF and OPN in OC patients with clinical high stage (stage III and IV), poorly differentiated, ascites, recurrence and metastasis were significantly higher than those in patients with clinical low stage (stage I and II), well differentiated, no ascites and no recurrence and metastasis (P<0.05). With the disappearance of the tumor or the decrease of tumor load, the serum marker levels after treatment were significantly lower than that before treatment (P<0.05). The sensitivity and accuracy of the combined examination in the diagnosis of OC were obviously improved compared with the single and partial combined examinations (P<0.05). In conclusion, combined examination can significantly improve the sensitivity and accuracy of OC, which is conducive to early diagnosis and clinical intervention of OC.
引用
收藏
页码:2028 / 2034
页数:7
相关论文
共 50 条
  • [31] Clinical effects of debulking surgery combined with neoadjuvant chemotherapy in treating ovarian cancer and its influence on tumor markers and immune function
    Yan, Huijuan
    Wang, Weiwei
    Wang, Shengchao
    Yan, Chunmei
    Zhu, Li
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (11) : 2475 - 2479
  • [32] Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer
    Wang, Yun-Feng
    Feng, Fei-Ling
    Zhao, Xu-Hong
    Ye, Zhen-Xiong
    Zeng, He-Ping
    Li, Zhen
    Jiang, Xiao-Qing
    Peng, Zhi-Hai
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) : 4085 - 4092
  • [33] Significance of serum CA-125 combined with CEA and HE-4 in diagnosis of epithelial ovarian cancer
    Tuerxun, Hanikezi
    Tuerxun, Manrepa
    Maimaitituersun, Guzailinuer
    Yilihamu, Yilidana
    Maimaitiming, Wuriguli
    Aierken, Gulizapar
    Aili, Zufeiya
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 4156 - 4161
  • [34] Utility of a Combined Panel of Six Serum Tumor Markers for Lung Cancer
    Molina, Rafael
    Marrades, Ramon
    Reguart, Noemi
    Agusti, Alvar
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S181 - S182
  • [35] Diagnosis of Lung Cancer Based on Plasma Metabolomics Combined with Serum Markers
    Zhang, Dong
    Tong, Lingxia
    Wang, Qingjun
    Cao, Yunfeng
    Gao, Yu
    Yang, Donghua
    Bao, Tianhao
    Zhu, Zhitu
    ONCOLOGIE, 2020, 22 (02) : 75 - 82
  • [36] Effect of the combined use of docetaxel, cisplatin and apatinib mesylate on serum tumor markers and prognosis in advanced ovarian cancer patients
    Shen, Miao
    Cheng, Jianxia
    Kong, Jianping
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (03) : 603 - 610
  • [37] PREDICTIVE VALUE OF THE COMBINATION OF SERUM MARKERS, CA125, CASA AND TPS IN OVARIAN-CANCER
    DEVINE, PL
    MCGUCKIN, MA
    QUIN, RJ
    WARD, BG
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (03) : 170 - 178
  • [38] Value of joint detection of serum TK-1 and tumor markers in gastric cancer screening
    Zhen, Shuanping
    Gao, Ziying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10294 - 10301
  • [40] Current clinical application of serum biomarkers to detect ovarian cancer
    Nowak, Marek
    Janas, Lukasz
    Stachowiak, Grzegorz
    Stetkiewicz, Tomasz
    Wilczynski, Jacek R.
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2015, 14 (04): : 254 - 259